Sommaire

Numéro précédent | Numéro suivant

• • ·Clinical trial–derived risk model may not generalize to real-world patients with acute coronary syndrome

    Page :1020-1027

    Andrew T. Yan, Philip Jong, Raymond T. Yan, Mary Tan, David Fitchett, Chi-Ming Chow, Matthew T. Roe, Karen S. Pieper, Anatoly Langer, Shaun G. Goodman, for the Canadian Acute Coronary Syndromes (ACS) Registry Investigators a b c

    Résumé Résumé Plan Plan  
• • ·Pulsed wave tissue Doppler-derived myocardial performance index for the assessment of left ventricular thrombus formation risk after acute myocardial infarction

    Page :1102-1108

    Remzi Yilmaz, Sukru Celik, Merih Baykan, Cihan Orem, Hasan Kasap, Ismet Durmus, Cevdet Erdol

    Résumé Résumé Plan Plan  
• • ·Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: The 30-day outcome associated with normal left ventricular wall motion

    Page :1096-1101

    Patrick Weston, John H. Alexander, Manesh R. Patel, Charles Maynard, Lawrence Crawford, Galen S. Wagner

    Résumé Résumé Plan Plan  
• • ·Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure

    Page :964-970

    Kunihiro Yamada, Hidetsugu Asanoi, Hiroshi Ueno, Shuji Joho, Junya Takagawa, Tomoki Kameyama, Tadakazu Hirai, Takashi Nozawa, Hiroshi Inoue

    Résumé Résumé Plan Plan  
• • ·The continuing importance of prior stroke in STEMI patients

    Page :931-936

    Michael A. Sloan

    
• • ·Direct Stenting Compared to Conventional Stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): A multicenter, open label, randomized, controlled efficacy study

    Page :1007-1011

    Huay Cheem Tan, Yean Teng Lim, Tuan L.A. Rosli, Kui Hian Sim, Kim Heung Tan, Chi Hang Lee, Omar Ismail, Wan Azman

    Résumé Résumé Plan Plan
• • ·Peer group benchmarks are not appropriate for health care quality report cards

    Page :921-923

    Patrick S. Romano

    
• • ·GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention

    Page :1003-1006

    Jose E. Exaire, Sorin J. Brener, Stephen G. Ellis, Jay S. Yadav, Deepak L. Bhatt

    Résumé Résumé Plan Plan
• • ·Acute ST-segment elevation myocardial infarction and prior stroke: An analysis from the Magnesium in Coronaries (MAGIC) trial

    Page :1012-1019

    Howard A. Cooper, Michael J. Domanski, Yves Rosenberg, James Norman, Judith H. Scott, Susan F. Assmann, Sonja M. McKinlay, Judith S. Hochman, Elliott M. Antman, the MAGIC Trial Investigators

    Résumé Résumé Plan Plan  
• • ·Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials

    Page :990-997

    Mark D. Schleinitz, Ingram Olkin, Paul A. Heidenreich

    Résumé Résumé Plan Plan  
• • ·Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction

    Page :1068-1078

    Salim Yusuf, Shamir R. Mehta, Rafael Díaz, Ernesto Paolasso, Prem Pais, Denis Xavier, Changchun Xie, Rashid J. Ahmed, Khawar Khazmi, Jun Zhu, Lisheng Liu, CREATE-ECLA Investigators and Steering Committee

    Résumé Résumé Plan Plan  
• • ·Table of contents

    Page :A1

    
• • ·Editorial board

    Page :A5

    
• • ·Information for authors

    Page :A6

    
• • ·Information for readers

    Page :A8

    
• • ·Change of address

    Page :923

     
• • ·Glucose-insulin-potassium therapy for acute myocardial infarction: What goes around comes around

    Page :924-930

    Charlie I. Gnaim, Darren K. McGuire

    Plan Plan  
• • ·Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: A meta-analysis of randomized, controlled trials

    Page :937-943

    João Otávio de Queiroz Fernandes Araújo, Henrique Horta Veloso, Joyce Morgana Braga De Paiva, Mohamed Wafae Filho, Angelo Amato Vincenzo De Paola

    Résumé Résumé Plan Plan  
• • ·Benefits of inpatient initiation of β-blockers

    Page :944-950

    Hector O. Ventura

    Résumé Résumé Plan Plan  
• • ·Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)

    Page :951-957

    Lawrence Baruch, Robert D. Glazer, Nora Aknay, Johan Vanhaecke, J. Thomas Heywood, Inder Anand, Henry Krum, Allen Hester, Jay N. Cohn

    Résumé Résumé Plan Plan  
• • ·β-blocker therapy in patients with heart failure in the urban setting: Moving beyond clinical trials

    Page :958-963

    Jerry D. Estep, Sameer K. Mehta, Fatema Uddin, Louise King, Kathleen H. Toto, Lauren L. Nelson, Daniel L. Dries, Clyde W. Yancy, Mark H. Drazner

    Résumé Résumé Plan Plan  
• • ·Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure

    Page :971-978

    Kamala P. Tamirisa, Keith D. Aaronson, Todd M. Koelling

    Résumé Résumé Plan Plan  
• • ·Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: The Jackson Cohort of the Atherosclerotic Risk in Communities Study

    Page :979-984

    Ervin Fox, Doug Harkins, Herman Taylor, Michael McMullan, Hui Han, Tandaw Samdarshi, Robert Garrison, Thomas Skelton

    Résumé Résumé Plan Plan  
• • ·Autonomic profile and arrhythmic risk stratification after surgical repair of tetralogy of Fallot

    Page :985-989

    Antonio Franco Folino, Giulia Russo, Barbara Bauce, Elisa Mazzotti, Luciano Daliento

    Résumé Résumé Plan Plan
• • ·Impact of female sex on outcome after percutaneous coronary intervention

    Page :998-1002

    John H. Chiu, Deepak L. Bhatt, Khaled M. Ziada, Derek P. Chew, Patrick L. Whitlow, A. Michael Lincoff, Stephen G. Ellis, Eric J. Topol

    Résumé Résumé Plan Plan  
• • ·Loratidine improves ischemic parameters of exercise stress test in patients with acute myocardial infarction

    Page :1019-1023

    Okan Erdogan, Armagan Altun, Sabri Gazi, Gultac Ozbay

    Résumé Résumé Plan Plan  
• • ·How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry

    Page :1028-1033

    Daniel G. Hackam, Mary K.K. Tan, George N. Honos, Lawrence A. Leiter, Anatoly Langer, Shaun G. Goodman, Vascular Protection (VP) Registry Investigators

    Résumé Résumé Plan Plan  
• • ·Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes

    Page :1034-1040

    Matthew J. Kolek, John F. Carlquist, Joseph B. Muhlestein, Bryant M. Whiting, Benjamin D. Horne, Tami L. Bair, Jeffrey L. Anderson

    Résumé Résumé Plan Plan
• • ·Impact of the choice of benchmark on the conclusions of hospital report cards

    Page :1041-1046

    Peter C. Austin, David A. Alter, Geoffrey M. Anderson, Jack V. Tu

    Résumé Résumé Plan Plan  
• • ·Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study

    Page :1047-1052

    Olaf Schouten, Don Poldermans, Loes Visser, Miklos D. Kertai, Jan Klein, Hero van Urk, Maarten L. Simoons, Louis L. van de Ven, Maarten Vermeulen, Jeroen J. Bax, Thomas W. Lameris, Eric Boersma

    Plan Plan  
• • ·Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: The rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE)

    Page :1053-1059

    Prakash C. Deedwania, SAGE Steering Committee and Investigators

    Résumé Résumé Plan Plan  
• • ·Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: Design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study

    Page :1060-1067

    Stefan N. Willich, Jacqueline Müller-Nordhorn, Frank Sonntag, Heinz Völler, Wolfgang Meyer-Sabellek, Karl Wegscheider, Eberhard Windler, Hugo Katus

    Résumé Résumé Plan Plan  
• • ·Pulsed-wave tissue Doppler quantification of systolic and diastolic function of viable and nonviable myocardium in patients with ischemic cardiomyopathy

    Page :1079-1084

    Manolis Bountioukos, Arend F.L. Schinkel, Jeroen J. Bax, Elena Biagini, Vittoria Rizzello, Boudewijn J. Krenning, Eleni C. Vourvouri, Jos R.T.C. Roelandt, Don Poldermans

    Résumé Résumé Plan Plan  
• • ·Methodology for improved detection of coronary stenoses with computed tomographic angiography

    Page :1085-1090

    Matthew J. Budoff, Bin Lu, Jerold S. Shinbane, Lynn Chen, Janis Child, Sivi Carson, SongShou Mao

    Résumé Résumé Plan Plan  
• • ·Real-time 3-dimensional echocardiography in assessing atrial and ventricular septal defects: An echocardiographic-surgical correlative study

    Page :1091-1095

    Tsung O. Cheng, Ming-Xing Xie, Xin-Fang Wang, Ying Wang, Qing Lu

    Résumé Résumé Plan Plan  
• • ·Author index

    Page :1109-1123

    
• • ·Subject index

    Page :1124-1140

    
• • ·Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

    Page :e1

    J.M. Alvarez

    
• • ·Reply

    Page :e2

    Mohamed Y. Rady, Daniel J. Johnson

    
• • ·Letter to the editor

    Page :e3

    Jeffrey A. Johnson, Sumit R. Majumdar

    
• • ·Reply

    Page :e4

    Darren K. McGuire, L.Kristin Newby

    
• • ·Letter to the editor

    Page :e5

    Steven G. Coca, Gregory K. Buller

    
• • ·Reply

    Page :e6

    Kenji Okumura, Junichiro Kondo, Toyoaki Murohara, Kenji Okumura, Junichiro Kondo, Toyoaki Murohara

    
• • ·The potential benefits of trimetazidine in patients with diabetes and ischemic cardiomyopathy

    Page :e7

    Panagiotis Korantzopoulos, Evaggelos Kountouris, Konstantinos Siogas, Dimitrios Galaris

    
• • ·Reply

    Page :e8

    Gabriele Fragasso, Altin Palloshi, Alberto Margonato

    
• • ·Cardiac abnormalities in myotonic dystrophy type 1

    Page :e9

    Josef Finsterer, Claudia Stöllberger

    
• • ·The prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I

    Page :e10

    Deepak Bhakta, Miriam R. Lowe, William J. Groh